A detailed history of Roundview Capital LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Roundview Capital LLC holds 3,445 shares of LLY stock, worth $2.64 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
3,445
Previous 3,354 2.71%
Holding current value
$2.64 Million
Previous $3.04 Million 0.53%
% of portfolio
0.23%
Previous 0.24%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $70,264 - $87,361
91 Added 2.71%
3,445 $3.05 Million
Q2 2024

Aug 09, 2024

BUY
$724.87 - $909.04 $133,376 - $167,263
184 Added 5.8%
3,354 $3.04 Million
Q1 2024

May 06, 2024

BUY
$592.2 - $792.28 $199,571 - $266,998
337 Added 11.9%
3,170 $2.47 Million
Q4 2023

Feb 12, 2024

BUY
$525.19 - $619.13 $265,220 - $312,660
505 Added 21.69%
2,833 $1.65 Million
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $17,822 - $24,571
41 Added 1.79%
2,328 $1.25 Million
Q2 2023

Aug 09, 2023

SELL
$350.74 - $468.98 $28,059 - $37,518
-80 Reduced 3.38%
2,287 $1.07 Million
Q1 2023

May 09, 2023

SELL
$310.63 - $364.82 $123,320 - $144,833
-397 Reduced 14.36%
2,367 $812,000
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $52,412 - $61,071
163 Added 6.27%
2,764 $1.01 Million
Q3 2022

Nov 10, 2022

BUY
$296.48 - $337.87 $96,948 - $110,483
327 Added 14.38%
2,601 $841,000
Q2 2022

Aug 11, 2022

BUY
$278.73 - $327.27 $60,763 - $71,344
218 Added 10.6%
2,274 $737,000
Q1 2022

May 11, 2022

BUY
$234.69 - $291.66 $12,438 - $15,457
53 Added 2.65%
2,056 $589,000
Q3 2021

Nov 10, 2021

BUY
$221.6 - $272.71 $88,640 - $109,083
400 Added 24.95%
2,003 $463,000
Q1 2021

May 14, 2021

BUY
$164.32 - $212.72 $49,296 - $63,816
300 Added 23.02%
1,603 $299,000
Q4 2020

Feb 08, 2021

BUY
$130.46 - $172.63 $169,989 - $224,936
1,303 New
1,303 $220,000
Q3 2020

Nov 05, 2020

SELL
$146.22 - $169.13 $188,185 - $217,670
-1,287 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$136.42 - $164.18 $175,572 - $211,299
1,287 New
1,287 $211,000
Q1 2020

May 11, 2020

SELL
$119.05 - $147.35 $898,589 - $1.11 Million
-7,548 Closed
0 $0
Q4 2019

Feb 10, 2020

BUY
$106.92 - $132.43 $249,123 - $308,561
2,330 Added 44.65%
7,548 $992,000
Q2 2019

Aug 12, 2019

SELL
$110.79 - $129.32 $49,855 - $58,194
-450 Reduced 7.94%
5,218 $578,000
Q1 2019

May 09, 2019

SELL
$111.31 - $131.02 $26,157 - $30,789
-235 Reduced 3.98%
5,668 $735,000
Q4 2018

Feb 13, 2019

BUY
$105.9 - $118.64 $42,465 - $47,574
401 Added 7.29%
5,903 $683,000
Q2 2018

Aug 10, 2018

BUY
$75.7 - $86.88 $416,501 - $478,013
5,502 New
5,502 $469,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Roundview Capital LLC Portfolio

Follow Roundview Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roundview Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Roundview Capital LLC with notifications on news.